Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6635324rdf:typepubmed:Citationlld:pubmed
pubmed-article:6635324lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:6635324lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6635324pubmed:issue2lld:pubmed
pubmed-article:6635324pubmed:dateCreated1983-12-20lld:pubmed
pubmed-article:6635324pubmed:abstractTextThe effect of 3-methylcholanthrene (3-MC), an inducer of the mixed function oxidases system (MFOS), was investigated in male Wistar rats in relation to plasmatic cholesterol and hepatic glucose-6-phosphate dehydrogenase (G-6-PD). 3-MC induced an increase in total cholesterol; the maximal increase was seen 2 days after treatment (50%). The increase in total cholesterol was followed by an augmentation in cholesterol HDL. 3-MC treatment resulted also in an increase of hepatic G-6-PD.lld:pubmed
pubmed-article:6635324pubmed:languageenglld:pubmed
pubmed-article:6635324pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6635324pubmed:citationSubsetIMlld:pubmed
pubmed-article:6635324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6635324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6635324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6635324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6635324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6635324pubmed:statusMEDLINElld:pubmed
pubmed-article:6635324pubmed:monthAuglld:pubmed
pubmed-article:6635324pubmed:issn0034-5164lld:pubmed
pubmed-article:6635324pubmed:authorpubmed-author:PaniPPlld:pubmed
pubmed-article:6635324pubmed:authorpubmed-author:DessìSSlld:pubmed
pubmed-article:6635324pubmed:authorpubmed-author:BatettaBBlld:pubmed
pubmed-article:6635324pubmed:authorpubmed-author:LaconiEElld:pubmed
pubmed-article:6635324pubmed:issnTypePrintlld:pubmed
pubmed-article:6635324pubmed:volume41lld:pubmed
pubmed-article:6635324pubmed:ownerNLMlld:pubmed
pubmed-article:6635324pubmed:authorsCompleteYlld:pubmed
pubmed-article:6635324pubmed:pagination333-6lld:pubmed
pubmed-article:6635324pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:meshHeadingpubmed-meshheading:6635324-...lld:pubmed
pubmed-article:6635324pubmed:year1983lld:pubmed
pubmed-article:6635324pubmed:articleTitleEffect of 3-MC on cholesterolemia and hepatic G-6-PD.lld:pubmed
pubmed-article:6635324pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6635324pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed